表紙:血漿療法の世界市場規模:タイプ別、供給元別、用途別、エンドユーザー別、地域別の予測(2022年~2028年)
市場調査レポート
商品コード
1071788

血漿療法の世界市場規模:タイプ別、供給元別、用途別、エンドユーザー別、地域別の予測(2022年~2028年)

Global Plasma Therapy Market Size study, By Type (Pure PRP, Leucocyte-rich PRP, Pure Platelet-rich Fibrin, Leukocyte-rich Fibrin ), By Source, By Application, By End User, and Regional Forecasts 2022-2028

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
血漿療法の世界市場規模:タイプ別、供給元別、用途別、エンドユーザー別、地域別の予測(2022年~2028年)
出版日: 2022年04月20日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の血漿療法の市場規模は、2021年に約2億6,108万米ドルとなり、2022年~2028 年の予測期間中に14.0%を超える健全な成長率で成長すると予測されています。

当レポートでは、世界の血漿療法市場について調査分析し、市場動向、業界分析、COVID-19の影響、セグメント別・地域別の市場分析、企業プロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の血漿療法市場の定義と範囲

第3章 世界の血漿療法市場力学

  • 血漿療法市場の影響分析(2020年~2028年)

第4章 世界の血漿療法市場の業界分析

  • ポーターのファイブフォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論
  • 主要投資機会
  • 主要成功戦略

第5章 リスク評価:COVID-19の影響

    • 業界に対するCOVID-19の全体的な影響の評価
    • COVID-19前・COVID-19後の市場シナリオ

第6章 世界の血漿療法市場:タイプ別

  • 市場スナップショット
  • 実績 - 潜在性分析
  • 推定と予測(2018年~2028年)
  • サブセグメント分析
    • 純粋なPRP
    • 白血球に富んだPRP
    • 純粋な多血小板フィブリン(PRF)
    • 白血球に富んだ多血小板フィブリン(L-PRF)

第7章 世界の血漿療法市場:供給元別

  • 市場スナップショット
  • 実績 - 潜在性分析
  • 推定と予測(2018年~2028年)
  • サブセグメント分析
    • 自己移植
    • 同種異系

第8章 世界の血漿療法市場:用途別

  • 市場スナップショット
  • 実績 - 潜在性分析
  • 推定と予測(2018年~2028年)
  • サブセグメント分析
    • 整形外科
    • 皮膚科
    • 歯科
    • 心筋損傷
    • 神経損傷
    • その他

第9章 世界の血漿療法市場:エンドユーザー別

  • 市場スナップショット
  • 実績 - 潜在性分析
  • 推定と予測(2018年~2028年)
  • サブセグメント分析
    • 病院・クリニック
    • 研究機関

第10章 世界の血漿療法市場:地域別の分析

  • 地域別の市場スナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • メキシコ
  • その他の地域

第11章 競合情報

  • 主要市場戦略
  • 企業プロファイル
    • BioLife Plasma Services
    • Cambryn Biologics LLC
    • Biotest AG
    • CSL Ltd.
    • Grifols International S.A.
    • Kedrion S.p.A.
    • LFB S.A.
    • Bio Products Laboratory Ltd.
    • China Biologic Products, Inc.
    • Octapharma AG

第12章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Plasma Therapy Market, report scope
  • TABLE 2. Global Plasma Therapy Market estimates & forecasts by Region 2018-2028 (USD Million)
  • TABLE 3. Global Plasma Therapy Market estimates & forecasts by Type 2018-2028 (USD Million)
  • TABLE 4. Global Plasma Therapy Market estimates & forecasts by Source 2018-2028 (USD Million)
  • TABLE 5. Global Plasma Therapy Market estimates & forecasts by Application 2018-2028 (USD Million)
  • TABLE 6. Global Plasma Therapy Market estimates & forecasts by End User 2018-2028 (USD Million)
  • TABLE 7. Global Plasma Therapy Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 8. Global Plasma Therapy Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 9. Global Plasma Therapy Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 10. Global Plasma Therapy Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 11. Global Plasma Therapy Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 12. Global Plasma Therapy Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 13. Global Plasma Therapy Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 14. Global Plasma Therapy Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 15. Global Plasma Therapy Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 16. Global Plasma Therapy Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 17. U.S. Plasma Therapy Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 18. U.S. Plasma Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 19. U.S. Plasma Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 20. Canada Plasma Therapy Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 21. Canada Plasma Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 22. Canada Plasma Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 23. UK Plasma Therapy Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 24. UK Plasma Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 25. UK Plasma Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 26. Germany Plasma Therapy Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 27. Germany Plasma Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 28. Germany Plasma Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 29. RoE Plasma Therapy Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 30. RoE Plasma Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 31. RoE Plasma Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 32. China Plasma Therapy Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 33. China Plasma Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 34. China Plasma Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 35. India Plasma Therapy Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 36. India Plasma Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 37. India Plasma Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 38. Japan Plasma Therapy Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 39. Japan Plasma Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 40. Japan Plasma Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 41. RoAPAC Plasma Therapy Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 42. RoAPAC Plasma Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 43. RoAPAC Plasma Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 44. Brazil Plasma Therapy Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 45. Brazil Plasma Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 46. Brazil Plasma Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 47. Mexico Plasma Therapy Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 48. Mexico Plasma Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 49. Mexico Plasma Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 50. RoLA Plasma Therapy Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 51. RoLA Plasma Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 52. RoLA Plasma Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 53. Row Plasma Therapy Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 54. Row Plasma Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 55. Row Plasma Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 56. List of secondary sources, used in the study of global Plasma Therapy Market
  • TABLE 57. List of primary sources, used in the study of global Plasma Therapy Market
  • TABLE 58. Years considered for the study
  • TABLE 59. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Plasma Therapy Market, research methodology
  • FIG 2. Global Plasma Therapy Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Plasma Therapy Market, key trends 2021
  • FIG 5. Global Plasma Therapy Market, growth prospects 2022-2028
  • FIG 6. Global Plasma Therapy Market, porters 5 force model
  • FIG 7. Global Plasma Therapy Market, pest analysis
  • FIG 8. Global Plasma Therapy Market, value chain analysis
  • FIG 9. Global Plasma Therapy Market by segment, 2018 & 2028 (USD Million)
  • FIG 10. Global Plasma Therapy Market by segment, 2018 & 2028 (USD Million)
  • FIG 11. Global Plasma Therapy Market by segment, 2018 & 2028 (USD Million)
  • FIG 12. Global Plasma Therapy Market by segment, 2018 & 2028 (USD Million)
  • FIG 13. Global Plasma Therapy Market by segment, 2018 & 2028 (USD Million)
  • FIG 14. Global Plasma Therapy Market, regional snapshot 2018 & 2028
  • FIG 15. North America Plasma Therapy Market 2018 & 2028 (USD Million)
  • FIG 16. Europe Plasma Therapy Market 2018 & 2028 (USD Million)
  • FIG 17. Asia pacific Market 2018 & 2028 (USD Million)
  • FIG 18. Latin America Plasma Therapy Market 2018 & 2028 (USD Million)
  • FIG 19. Global Plasma Therapy Market, company Market share analysis (2021)
目次

Global Plasma Therapy Market is valued approximately USD 261.08 million in 2021 and is anticipated to grow with a healthy growth rate of more than 14.0% over the forecast period 2022-2028.

Plasma is one of the components that are present in the blood, which carries essential nutrients, hormones, and proteins to the body parts that need it. The primary objective of plasma therapy is to transfer the immunity of a healthy individual to another patient. The plasma generally encompasses a large number of antibodies that aid in curing various diseases. The growing incidences of sports injuries, rising number of patients suffering from androgenic alopecia, arthritis, and orthopedic disorders, and increasing adoption of platelet-rich plasma in various therapeutic applications are the chief factors that accelerate the market growth across the globe. For instance, according to the Centers for Disease Control and Prevention, in 2015, nearly 54 million adult population were diagnosed with arthritis in the United States. Also, the amount is projected to reach approximately 72 million by the end of 2030. Consequentially, the rising prevalence of arthritis is likely to fuel the demand for plasma therapy, which, in turn, accelerates market growth. However, the lack of reimbursement policies and restricted use of

platelet-rich plasma (PRP) for patients suffering from diabetes and kidney ailments impedes the growth of the market over the forecast period of 2022-2028. Also, the development of the emerging economies and rising expenditure in the healthcare sector are anticipated to act as a catalyzing factor for the market demand during the forecast period.

The key regions considered for the global Plasma Therapy market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the increasing investment for R&D activities and the presence of leading market players in the region. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the growing presence of the geriatric population as well as rising incidences of orthopedic disorder, would create lucrative growth prospects for the Plasma Therapy market across the Asia-Pacific region.

Major market players included in this report are:

BioLife Plasma Services

Cambryn Biologics LLC

Biotest AG

CSL Ltd.

Grifols International S.A.

Kedrion S.p.A.

LFB S.A.

Bio Products Laboratory Ltd.

China Biologic Products, Inc.

Octapharma AG

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Pure PRP

Leucocyte-rich PRP

Pure Platelet-rich Fibrin (PRF)

Leukocyte-rich Fibrin (L-PRF)

By Source:

Autologous

Allogenic

By Application:

Orthopedics

Dermatology

Dental

Cardiac Muscle Injury

Nerve Injury

Others

By End User:

Hospitals & Clinics

Research Institutions

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Plasma Therapy Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
    • 1.2.1. Global Plasma Therapy Market, by Region, 2020-2028 (USD Million)
    • 1.2.2. Global Plasma Therapy Market, by Type, 2020-2028 (USD Million)
    • 1.2.3. Global Plasma Therapy Market, by Source, 2020-2028 (USD Million)
    • 1.2.4. Global Plasma Therapy Market, by Application, 2020-2028 (USD Million)
    • 1.2.5. Global Plasma Therapy Market, by End User, 2020-2028 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Plasma Therapy Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Plasma Therapy Market Dynamics

  • 3.1. Plasma Therapy Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising incidences of arthritis
      • 3.1.1.2. Increasing use of platelet-rich plasma in various therapeutic areas
    • 3.1.2. Market Challenges
      • 3.1.2.1. Lack of reimbursement policies
      • 3.1.2.2. Restricted use of PRP for patients suffering from diabetes and kidney ailments
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Development of the emerging economies
      • 3.1.3.2. Rising expenditure in the healthcare sector

Chapter 4. Global Plasma Therapy Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Plasma Therapy Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global Plasma Therapy Market by Type, Performance - Potential Analysis
  • 6.3. Global Plasma Therapy Market Estimates & Forecasts by Type 2018-2028 (USD Million)
  • 6.4. Plasma Therapy Market, Sub Segment Analysis
    • 6.4.1. Pure PRP
    • 6.4.2. Leucocyte-rich PRP
    • 6.4.3. Pure Platelet-rich Fibrin (PRF)
    • 6.4.4. Leukocyte-rich Fibrin (L-PRF)

Chapter 7. Global Plasma Therapy Market, by Source

  • 7.1. Market Snapshot
  • 7.2. Global Plasma Therapy Market by Source, Performance - Potential Analysis
  • 7.3. Global Plasma Therapy Market Estimates & Forecasts by Source 2018-2028 (USD Million)
  • 7.4. Plasma Therapy Market, Sub Segment Analysis
    • 7.4.1. Autologous
    • 7.4.2. Allogenic

Chapter 8. Global Plasma Therapy Market, by Application

  • 8.1. Market Snapshot
  • 8.2. Global Plasma Therapy Market by Application, Performance - Potential Analysis
  • 8.3. Global Plasma Therapy Market Estimates & Forecasts by Application 2018-2028 (USD Million)
  • 8.4. Plasma Therapy Market, Sub Segment Analysis
    • 8.4.1. Orthopedics
    • 8.4.2. Dermatology
    • 8.4.3. Dental
    • 8.4.4. Cardiac Muscle Injury
    • 8.4.5. Nerve Injury
    • 8.4.6. Others

Chapter 9. Global Plasma Therapy Market, by End User

  • 9.1. Market Snapshot
  • 9.2. Global Plasma Therapy Market by End User, Performance - Potential Analysis
  • 9.3. Global Plasma Therapy Market Estimates & Forecasts by End User 2018-2028 (USD Million)
  • 9.4. Plasma Therapy Market, Sub Segment Analysis
    • 9.4.1. Hospitals & Clinics
    • 9.4.2. Research Institutions

Chapter 10. Global Plasma Therapy Market, Regional Analysis

  • 10.1. Plasma Therapy Market, Regional Market Snapshot
  • 10.2. North America Plasma Therapy Market
    • 10.2.1. U.S. Plasma Therapy Market
      • 10.2.1.1. Type estimates & forecasts, 2018-2028
      • 10.2.1.2. Source estimates & forecasts, 2018-2028
      • 10.2.1.3. Application estimates & forecasts, 2018-2028
      • 10.2.1.4. End User estimates & forecasts, 2018-2028
    • 10.2.2. Canada Plasma Therapy Market
  • 10.3. Europe Plasma Therapy Market Snapshot
    • 10.3.1. U.K. Plasma Therapy Market
    • 10.3.2. Germany Plasma Therapy Market
    • 10.3.3. France Plasma Therapy Market
    • 10.3.4. Spain Plasma Therapy Market
    • 10.3.5. Italy Plasma Therapy Market
    • 10.3.6. Rest of Europe Plasma Therapy Market
  • 10.4. Asia-Pacific Plasma Therapy Market Snapshot
    • 10.4.1. China Plasma Therapy Market
    • 10.4.2. India Plasma Therapy Market
    • 10.4.3. Japan Plasma Therapy Market
    • 10.4.4. Australia Plasma Therapy Market
    • 10.4.5. South Korea Plasma Therapy Market
    • 10.4.6. Rest of Asia Pacific Plasma Therapy Market
  • 10.5. Latin America Plasma Therapy Market Snapshot
    • 10.5.1. Brazil Plasma Therapy Market
    • 10.5.2. Mexico Plasma Therapy Market
  • 10.6. Rest of The World Plasma Therapy Market

Chapter 11. Competitive Intelligence

  • 11.1. Top Market Strategies
  • 11.2. Company Profiles
    • 11.2.1. BioLife Plasma Services
      • 11.2.1.1. Key Information
      • 11.2.1.2. Overview
      • 11.2.1.3. Financial (Subject to Data Availability)
      • 11.2.1.4. Product Summary
      • 11.2.1.5. Recent Developments
    • 11.2.2. Cambryn Biologics LLC
    • 11.2.3. Biotest AG
    • 11.2.4. CSL Ltd.
    • 11.2.5. Grifols International S.A.
    • 11.2.6. Kedrion S.p.A.
    • 11.2.7. LFB S.A.
    • 11.2.8. Bio Products Laboratory Ltd.
    • 11.2.9. China Biologic Products, Inc.
    • 11.2.10. Octapharma AG

Chapter 12. Research Process

  • 12.1. Research Process
    • 12.1.1. Data Mining
    • 12.1.2. Analysis
    • 12.1.3. Market Estimation
    • 12.1.4. Validation
    • 12.1.5. Publishing
  • 12.2. Research Attributes
  • 12.3. Research Assumption